Here, we look at the obstacles that have prevented the further development of XRPD in the pharmaceutical industry, and the trends in instrumentation that are now breaking these barriers.
X-ray powder diffraction (XRPD) has a long association with the pharmaceutical industry. For many years the technique has been essential for obtaining the data necessary for securing patents, registering new products and for demonstrating compliance with industry regulations. However, despite the great potential XRPD offers for numerous other pharmaceutical applications, until recently there has been a bottleneck to its expansion.
Not registered yet?
Sign up for free today. By registering you will have free access to exclusive content including
- Webinars, presentations and videos
- Application notes, technical notes, articles, white papers and software downloads
And in addition you will receive
- Our regular eNews including the latest news, education, events and offers from Malvern Panalytical